Loading
Loading…
Loading…
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Finance CIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | Admitted-Finance |
| 2 | Admitted-Finance | Admitted-Finance |
| 3 | Admitted-Finance | Admitted-Finance |
| 4 | Admitted-Finance | Admitted-Finance |
Tender Value
Refer Docs
EMD Value
₹50,000
Closing Date
12 Feb 2024, 11:00 amClosed
Principal
VCSGGMSRI Srinagar Garhwal
As per Tender Document
2024_VGIMS_67267_1
MCS/E Tender/2023-24/Medicine I
Open Tender
Medicines
Item Wise
2 days
HNB Base Teaching Hospital Srinagar Garhwal
As per Tender Document
2 documents required · 2 mandatory
₹1,180
Principal
₹50,000
HNB Base Teaching Hospital Srinagar Garhwal
15 Mar 2024
5 Jan 2024
12 Feb 2024
5 Jan 2024
12 Feb 2024
11 Jan 2024
9 Jan 2024
INJ CIPROFLOXACIN 200MG/100ML.
INJ COMPUND RINGER'S LACTATE.
INJ DEXTROSE 10%.
INJ DEXTROSE 25%.
INJ DEXTROSE 5% +SODIUM CHLORIDE 0.9% (DNS)
INJ DEXTROSE 5% .
INJ LINEZOLID . 200MG/100ML
INJ LIVOFLOXACIN 500MG /100ML.
INJ MANNITOL 20%
INJ METRONIDAZOLE 500MG/100ML
INJ MOXIFLOXACIN INFUSION 0.4%
INJ MULTIPLE ELECTROLYTES & DEXTROSE TYPE III IP (ELECTROLYTE" M")
INJ MULTIPLE ELECTROLYTES & DEXTROSE TYPE I IP (ELECTROLYTE P )
INJ OFLOXACIN 200MG/100ML
INJ PARACETAMOL 1000mg
INJ SODIUM CHLORIDE 0.9%
INJ SODIUM CHLORIDE 3%
INJ.SODIUM CHLORIDE 0.9%
Cipla Ltd
Higgs Healthcare
EUROLIFE HEALTH CARE PVT LTD
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .